Sublimity Therapeutics – Funding to Develop New Drug
2018-07-19T14:50:26+01:00Sigmoid Pharma - now known as Sublimity Therapeutics has closed an enormous $64m round of financing to fund the clinical development of a new drug.
Sigmoid Pharma - now known as Sublimity Therapeutics has closed an enormous $64m round of financing to fund the clinical development of a new drug.